期刊
LUPUS
卷 23, 期 12, 页码 1320-1323出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203314540354
关键词
Anti-domain I antibodies; thrombosis; pregnancy morbidity
类别
资金
- Arthritis Research UK Programme Grant [19423]
- Versus Arthritis [19423] Funding Source: researchfish
IgG antiphospholipid antibodies (aPL) against (2)-glycoprotein I ((2)GPI) can target any of its five domains; however, aPL against the N-terminal domain (anti-DI, aDI) are considered the most clinically relevant in the antiphospholipid syndrome (APS). Circulating levels of aDI are elevated in patients with APS compared with disease and healthy controls, and crucially aDI are prothrombotic in invivo and invitro models. In addition, human recombinant DI has been shown to abrogate aPL-induced thrombosis invivo. Therefore, although the potential of utilizing DI for management of APS is not yet fully defined, there is promise that DI could prove valuable both as a diagnostic and therapeutic tool.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据